Position in TRLV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$148,521
New position
Shares Held
15,109
first reported quarter
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 125 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026&PARTNERS holds $18,450,769 across 16 Drug Manufacturers - Specialty & Generic names. TRLV ranks #14 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
67,603 | $4,857,951 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,447 | $3,493,178 | |
| 3 | VTRS |
Viatris Inc
|
209,068 | $3,319,999 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
13,769 | $1,527,532 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
29,413 | $996,512 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
29,984 | $737,906 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
13,127 | $620,513 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
37,853 | $606,783 |
All Filings in TRLV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $148,521 | 15,109 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||